Skip to main content

Table 2 Demographic characteristics of the patients

From: Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever

Demographic characteristics (n = 12)
Age (years), mean ± SD 34.2 ± 10.3
Sex, M(%)/F (%) 6 (%50.0)/6 (%50.0)
Disease duration (years), mean ± SD 6.43 ± 6.90
Duration of amyloidosis (years), mean ± SD 3.9 ± 4.8
TCZ therapy duration (months), mean ± SD 17.5 ± 14.7
Number of applied TCZ doses, mean ± SD 15.3 ± 12.1
Co-existing diseases n (%)
Ankylosing spondylitis 4 (%33.3)
Crohn’s disease 1 (%8.3)